Biotech’s that stop doing this to their new product development teams get huge returns
NPD teams meeting too often, or not enough, are inefficient - optimized schedules double profitability of new products.
![ESG investors be warned, look for these [counterintuitive] signs in your portfolio](https://images.squarespace-cdn.com/content/v1/64b968f77321602fb2f87390/1704515454530-QW0P5N09LLGA98HU5F3C/iStock-green+investing.jpeg)
NPD teams meeting too often, or not enough, are inefficient - optimized schedules double profitability of new products.